BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 30094157)

  • 1. Multi-component relaxation in clinically isolated syndrome: Lesion myelination may predict multiple sclerosis conversion.
    Kitzler HH; Wahl H; Eisele JC; Kuhn M; Schmitz-Peiffer H; Kern S; Rutt BK; Deoni SCL; Ziemssen T; Linn J
    Neuroimage Clin; 2018; 20():61-70. PubMed ID: 30094157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.
    Kitzler HH; Su J; Zeineh M; Harper-Little C; Leung A; Kremenchutzky M; Deoni SC; Rutt BK
    Neuroimage; 2012 Feb; 59(3):2670-7. PubMed ID: 21920444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring in vivo lesion myelination dynamics: Longitudinal Myelin Water Imaging in early Multiple Sclerosis.
    Kitzler HH; Wahl H; Kuntke P; Deoni SCL; Ziemssen T; Linn J; Köhler C
    Neuroimage Clin; 2022; 36():103192. PubMed ID: 36162236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Normal-Appearing White Matter in Multiple Sclerosis Using Direct Visualization of Short Transverse Relaxation Time Component (ViSTa) Myelin Water Imaging and Gradient Echo and Spin Echo (GRASE) Myelin Water Imaging.
    Choi JY; Jeong IH; Oh SH; Oh CH; Park NY; Kim HJ; Lee J
    J Magn Reson Imaging; 2019 Apr; 49(4):1091-1098. PubMed ID: 30240519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS.
    Elkady AM; Wu Z; Leppert IR; Arnold DL; Narayanan S; Rudko DA
    Mult Scler Relat Disord; 2021 Nov; 56():103309. PubMed ID: 34688179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin content changes in Clinically Isolated Syndrome and Relapsing- Remitting Multiple Sclerosis: Associations with lesion type and severity of visuomotor impairment.
    Panou Τ; Kavroulakis E; Mastorodemos V; Pouli S; Kalaitzakis G; Spyridaki E; Maris TG; Simos P; Papadaki E
    Mult Scler Relat Disord; 2021 Sep; 54():103108. PubMed ID: 34198031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance.
    Papadaki E; Mastorodemos V; Panou T; Pouli S; Spyridaki E; Kavroulakis E; Kalaitzakis G; Maris TG; Simos P
    J Magn Reson Imaging; 2021 Oct; 54(4):1077-1087. PubMed ID: 33960066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis.
    O'Muircheartaigh J; Vavasour I; Ljungberg E; Li DKB; Rauscher A; Levesque V; Garren H; Clayton D; Tam R; Traboulsee A; Kolind S
    Hum Brain Mapp; 2019 May; 40(7):2104-2116. PubMed ID: 30648315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    Rudick RA; Lee JC; Nakamura K; Fisher E
    J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis.
    Caporale AS; Chiarelli AM; Biondetti E; Villani A; Lipp I; Di Censo D; Tomassini V; Wise RG
    Hum Brain Mapp; 2024 Jun; 45(9):e26761. PubMed ID: 38895882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin Water Atlas: A Template for Myelin Distribution in the Brain.
    Liu H; Rubino C; Dvorak AV; Jarrett M; Ljungberg E; Vavasour IM; Lee LE; Kolind SH; MacMillan EL; Traboulsee A; Lang DJ; Rauscher A; Li DKB; MacKay AL; Boyd LA; Kramer JLK; Laule C
    J Neuroimaging; 2019 Nov; 29(6):699-706. PubMed ID: 31347238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
    Kolčava J; Kočica J; Hulová M; Dušek L; Horáková M; Keřkovský M; Stulík J; Dostál M; Kuhn M; Vlčková E; Bednařík J; Benešová Y
    Mult Scler Relat Disord; 2020 Sep; 44():102262. PubMed ID: 32570179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative assessment of myelin-sensitive measures in multiple sclerosis patients and healthy subjects.
    Rahmanzadeh R; Weigel M; Lu PJ; Melie-Garcia L; Nguyen TD; Cagol A; La Rosa F; Barakovic M; Lutti A; Wang Y; Bach Cuadra M; Radue EW; Gaetano L; Kappos L; Kuhle J; Magon S; Granziera C
    Neuroimage Clin; 2022; 36():103177. PubMed ID: 36067611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis.
    Abel S; Vavasour I; Lee LE; Johnson P; Ristow S; Ackermans N; Chan J; Cross H; Laule C; Dvorak A; Schabas A; Hernández-Torres E; Tam R; Kuan AJ; Morrow SA; Wilken J; Rauscher A; Bhan V; Sayao AL; Devonshire V; Li DKB; Carruthers R; Traboulsee A; Kolind SH
    JAMA Netw Open; 2020 Sep; 3(9):e2014220. PubMed ID: 32990740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosis.
    Holmes RD; Vavasour IM; Greenfield J; Zhao G; Lee JS; Moore GRW; Tam R; Metz LM; Trablousee A; Li DKB; Laule C
    J Neuroimaging; 2021 Sep; 31(5):981-994. PubMed ID: 34128576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis.
    Neema M; Goldberg-Zimring D; Guss ZD; Healy BC; Guttmann CR; Houtchens MK; Weiner HL; Horsfield MA; Hackney DB; Alsop DC; Bakshi R
    Neuroimage; 2009 Jul; 46(3):633-41. PubMed ID: 19281850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
    Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C
    Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.